Company intelligence / Profile preview

3T Clinical

South San Francisco, California, United Statespmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Other

Overview

The company has transitioned from a research/platform focus to clinical-stage development. Its most advanced program targets MAGE-A3 and is on track for clinical trials. The proprietary platform enables rapid identification and validation of novel TCR targets, aiming to overcome resistance in immunologically 'cold' solid tumors such as MSS colorectal cancer. Early de-risking through functional validation helps avoid costly failures in later stages.

Therapeutic areas: OncologyImmunology
Modalities: T cell receptor therapyAntibody-based peptide-HLA therapeuticsSmall molecule
Industry: Biotech

Partnerships

Stanford University (exclusive license for discovery platform and assets)Parker Institute for Cancer Immunotherapy (seed funding/investment)Westlake Village BioPartnersLightspeed Venture Partners

Beyond the preview

Go deeper on 3T Clinical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3T Clinical.

Explore the full profile